Overview

Study in Postmenopausal Women to Investigate the Drug-drug Interaction (DDI) Between Itraconazole(ITZ) and Orally Administered Vilaprisan; Absolute Bioavailability Using Intravenous Microtracer Dose of [14C]Vilaprisan

Status:
Completed

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

This is a study in postmenopausal women to investigate the Drug-drug interaction (DDI) between itraconazole(ITZ) and orally administered vilaprisan; absolute bioavailability using intravenous microtracer dose of [14C]vilaprisan.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Hydroxyitraconazole
Itraconazole